RET and multiple endocrine neoplasia type 2A: However, as MEN 2A-related PCCs (as well as PCCs with somatic RET mutations) are very seldom malignant [1], this case made us unsure as to whether the PASS and GAPP systems are applicable to this specific subset of PCCs.